We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Accelerated Approvals Should Be Backed by Randomized Trials
Accelerated Approvals Should Be Backed by Randomized Trials
April 18, 2012
Drugmakers conducting postmarket clinical trials should be required to conduct randomized clinical trials, according to the FDA’s Oncologic Drugs Advisory Committee.